INTRODUCTION
Immaturity of the immune system in early childhood renders infants susceptible to the range of infections including life-threatening ones. Especially lower respiratory tract infections and sepsis amongst neonates and children aged less than 2 years cause the large number of mortality, globally (Shah & Robinson, 2014) (Carville et al, 2007; Schrag & Schuchat, 2005) (Lawn et al, 2006) . Causes of sudden unexplained infant death include accidental suffocation, sudden infant death syndrome, many maltreatment syndromes along with Human parechoviral infections (Shapiro-Mendoza et al, 2006) . None of the samples analysed showed positivity for HPeVs presence. Suboptimal biological sample, the seasonal pattern of HPeVs infections and use of CSF only as the biological specimen might be some plausible reasons for the negative finding. Present study is the first such attempt in Saudi Arabia and thus it is pertinent that more stringent future studies using biological specimen of varying origins must be conducted to analyse the presence of HPeVs associated with asymptomatic infections or mild disease to severe disease symptoms in neonates and infants especially under the age of 3 months, before ruling out Human Parechovirus (HPeV) presence.
Human parechoviruses (HPeVs) cause a range of ailments including mild diarrhea, sepsis and meningitis, affecting largely young infants and children. They are nonenveloped, positive-sense, singlestranded RNA viruses, in family Picornaviridae. Historically, HPeVs are classified within the Enterovirus (EV) genus with HPeV types 1 and 2 known as echovirus 22 and echovirus 23, respectively. The reclassification was based on the sequence analysis that demonstrated genetic and biologic differences between echovirus 22 and EV genus members (Hyypia et al, 1992) . So far, 16 HPeV genotypes have been characterized (Stanway & Hyypia, 1999) (www.picornaviridae.com/ parechovirus/hpev/hpev.htm).
While the association of HPeV1 and HPeV3 is established with asymptomatic infections (Boivin et al, 2005; Mizuta et al, 2012; Stanway et al, 2000) , clinical association of remaining HPeVs remains to be explored. HPeV1 and HPeV2 cause mild gastrointestinal and respiratory symptoms (Benschop et al, 2008; Harvala et al, 2008) , whereas HPeV3 causes serious sepsis-like syndrome, meningitis, encephalitis, and hepatitis in neonates and young infants (Boivin et al, 2005) . Most HPeV infections are asymptomatic or associated with mild respiratory and/or gastrointestinal symptoms (Stanway et al, 2000) , however, lot remains to be elucidated about the characteristics of HPeV3 infection as well as those of other HPeV types (Abzug, 2004; Drexler et al, 2009; Harvala et al, 2008; Renaud et al, 2011; Sedmak et al, 2010; Selvarangan et al, 2011; Verboon-Maciolek et al, 2008 (de Crom et al, 2016; Grist et al, 1978; Khetsuriani et al, 2006; Sawyer, 2002) . Infections may deteriorate into nonparalytic aseptic meningitis (1-2% of cases) or to poliomyelitis (0.1-1% of cases) (Cristanziano et al, 2015) .
Incidence of HPeV types is variable worldwide. Early studies show HPeV types 1-6 incidence globally, while HPeV genotypes 7-16 have only been reported scarcely. Prevalence of HPeV7, 8, 9 and 12 have been reported from South America and Asia in children with gastrointestinal symptoms or asymptomatic infection (Alam et al, 2015; Drexler et al, 2009; Li et al, 2009; Moore et al, 2015; Oberste et al, 2013; Zhang et al, 2011; Zhong et al, 2013) . Similarly, Genotypes 10, 11, 13, 14 and 15 have been found in samples from children with gastroenteritis conditions or asymptomatic children in Asia (Alam et al, 2015; Kim Pham et al, 2010; Oberste et al, 2013) .
The incidence shows a seasonal pattern in temperate climates, with different types cocirculating simultaneously (Kolehmainen et al, 2012) . The incidence of HPeV infection in Saudi Arabia is not known so far, as this infection generally go unnoticed, and more often underexplored (Benschop et al, 2008) .
Early study show an infection rate of more than 90 % with at least one HPeV type among the children of the age of 2 years and below (Harvala et al, 2010; Khatami et al, 2015; Tauriainen et al, 2007) . However, HPeV infections are uncommon in older children (Esposito et al, 2014) .
Aims and Objectives:
In the current study, the presence of HPeV infection was assessed during June 2016-May 2017 in CSF fluid obtained from young infants. The primary goal of this study was to obtain a deeper understanding of the epidemiological behaviour of parechoviruses and to examine their clinical associations in Albaha, Saudi Arabia, with an aim to investigate the connection of HPeV to severe infections in infants. HPeV RNA detection included real-time PCR protocols with one step and two steps. The cDNA synthesis for the two-step reaction was performed in a 40 μl reaction containing 10 μl of RNA template, 8 μl of reaction buffer, 50 pmol of HPeV-specific primer, 20 nmol of dNTP, 4 units of Recombinant RNasin© RNase inhibitor and 20 units of M-MLV reverse transcriptase (Promega, Madison, WI, USA).
MATERIALS AND METHODS
The PCR step was performed using a Maxima qPCR master mix kit (Thermo Scientific, Rockford, IL, USA) in a 25 μl reaction, containing 5 μl of cDNA product, 300 nM of primers, and 200 nM of probe. HPeV Typing PCR :
An RT-PCR targeted to the almost complete VP1-sequence area of the HPeV genome was used for genotyping HPeV-positive findings. The typing was performed using viral RNA directly extracted from the target sample. The positive PCR fragments observed by agarose gel electrophoresis were to be directed to sequencing using the same primers used in the typing RT-PCR. Sequencing reactions would be performed by MACROGEN® (Seoul, Korea) (Table  1 -3). 
Sequence Analysis and Phylogeny:
The data from genotyping the VP1 sequences would be compared with reference sequences using BLAST (Altschul et al, 1990; Thompson et al, 1994) and aligned using the CLUSTALW tool (Thompson et al, 1994) 
RESULTS AND DISCUSSION
The Parechovirus genus including human pathogens HPeVs is the relatively new genus of viruses. The HPeVs circulation among human populations is increasingly common but is restricted to the young infants and children presenting asymptomatically or with mild clinical symptoms. However, HPeVs presence can easily progress to severe infections in neonates. The current study aimed to analyse the HPeVs presence in CSF samples of infants and describe their involvement in associated paediatric diseases at Albaha, Saudi Arabia.
CSF samples were collected from the infants having general characteristics as follows (Table 4) . (Tapia et al, 2010) , Scotland (Harvala et al, 2008) .
The suboptimal biological sample is one plausible reason for the current negative finding in the light of an early report showing the presence of antibodies against HPeV1 in children aged less than one year establishing its absolute seroconversion during the early months of life (Stanway et al, 2000) . The second reason might be a seasonal pattern of HPeVs infections similar to that of human enteroviruses, occurring more frequently in one season than the other (Chieochansin et al, 2011; Fischer et al, 2014) . Since the present study is first of its kind in Saudi Arabia, it is hard to confer which seasonal pattern HPeVs might be following in the country.
The third reason might be the use of CSF only as the biological specimen. Serum, stool, middle-ear fluid, and nasopharyngeal aspirate samples should be used in addition to cerebrospinal fluid in future studies. Thus it can be concluded that more stringent future studies using biological specimen of varying origins should be conducted to analyse the presence of HPeVs associated with asymptomatic infections or mild disease to severe disease symptoms in neonates and infants especially under the age of 3 months.
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